Kim Eunseok, Kim Hye Su, Jung So-Young, Han Chang Hyun, Kim Young-Il
Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University, 62, Daehak-ro, Dong-gu, Daejeon, 34520, Republic of Korea.
Department of Acupuncture and Moxibustion Medicine, Dunsan Korean Medicine Hospital of Daejeon University, 75, Daedeok-daero 176 beon-gil, Seo-gu, Daejeon, 35235, Republic of Korea.
Trials. 2018 Dec 6;19(1):672. doi: 10.1186/s13063-018-3058-9.
This study aims to evaluate the efficacy and safety of thread-embedding acupuncture (TEA) with polydioxanone thread embedded at various acupoints, compared with sham TEA, for the treatment of non-specific chronic neck pain.
METHODS/DESIGN: This study will be an 8-week-long, two-armed, parallel, randomized, subject-assessor-blinded, sham-controlled pilot trial. Fifty eligible patients will be randomly allocated into the real TEA group or the sham TEA group. The real TEA group will receive TEA treatment at 14 fixed acupoints in the neck region. The sham TEA group will receive the same treatment as the real TEA group, but with a sham device with the thread removed. Both groups will receive treatment once a week for a total of four sessions. The primary outcome will be the mean change in the visual analog scale (VAS) from baseline to week 6 (2 weeks post intervention). Clinical relevance (ratio of the number of patients with decreases on the VAS of ≥15 mm or with percentiles ≥ 30% and ≥ 50% relative to baseline to the total number of patients), Neck Disability Index, pressure pain threshold, the Hospital Anxiety and Depression Scale, EuroQol 5-Dimensions questionnaire, Patient Global Impression of Change, blinding test, and adverse events will be used to assess secondary outcomes.
The results of this study will provide valuable data for a large-scale clinical trial to evaluate the clinical effects of polydioxanone TEA in the treatment of patients with non-specific chronic neck pain.
Clinical Research Information Service (CRIS), Republic of Korea, KCT0002452 . Registered on 6 September 2017.
本研究旨在评估在多个穴位植入聚对二氧环己酮线的埋线针灸(TEA)与假埋线针灸相比,治疗非特异性慢性颈部疼痛的疗效和安全性。
方法/设计:本研究将是一项为期8周的双臂、平行、随机、受试者与评估者双盲、假对照的试点试验。50名符合条件的患者将被随机分配到真埋线针灸组或假埋线针灸组。真埋线针灸组将在颈部区域的14个固定穴位接受埋线针灸治疗。假埋线针灸组将接受与真埋线针灸组相同的治疗,但使用移除了线的假装置。两组均每周接受一次治疗,共进行四次疗程。主要结局将是从基线到第6周(干预后2周)视觉模拟量表(VAS)的平均变化。临床相关性(VAS降低≥15 mm或相对于基线百分位数≥30%和≥50%的患者数量与患者总数之比)、颈部残疾指数、压痛阈值、医院焦虑抑郁量表、欧洲五维健康量表问卷、患者总体印象变化、盲法测试和不良事件将用于评估次要结局。
本研究结果将为大规模临床试验提供有价值的数据,以评估聚对二氧环己酮埋线针灸治疗非特异性慢性颈部疼痛患者的临床效果。
韩国临床研究信息服务中心(CRIS),KCT0002452。于2017年9月6日注册。